NCT05554718

Brief Summary

The present study examines whether a self-help app can reduce symptoms of social anxiety disorder.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
165

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 26, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

September 26, 2022

Status Verified

September 1, 2022

Enrollment Period

1 year

First QC Date

September 12, 2022

Last Update Submit

September 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in SAD-related symptom severity measured by the Liebowitz Social Anxiety Scale

    The LSAS is a clinician-rated interview designed to measure fear and avoidance in different social situations. The situations are rated on scale from 0 ("not at all" or "never") to 3 (severe" or "most of the time"), with higher scores indicating greater symptoms of social anxiety.

    change from baseline (week 0) to week 12 (post) and to week 36 (follow-up)

Secondary Outcomes (16)

  • Change in SAD-related symptoms measured by the Social Phobia Inventory (SPIN)

    change from baseline to week 12 (post) and to week 36 (follow-up)

  • Change in the Social Phobic Cognition Questionnaire (SPK)

    change from baseline to week 12 (post) and to week 36 (follow-up)

  • Pain and Disability Index (PDI)

    change from baseline to week 12 (post) and to week 36 (follow-up)

  • Beck Depression Inventory - Fast Screen (BDI-FS)

    change from baseline to week 12 (post) and to week 36 (follow-up)

  • World Health Organization Quality of Life (WHO-QOL-BREF)

    change from baseline to week 12 (post) and to week 36 (follow-up)

  • +11 more secondary outcomes

Study Arms (3)

App condition

EXPERIMENTAL

All participants will receive access to the developed social anxiety disorder (SAD) treatment app for 12 weeks.

Behavioral: Self-help Smartphone App

App with accompanying therapy sessions

EXPERIMENTAL

In addition to being able to use the app to treat social anxiety over a 12-week period, participants will receive a total of 8 video therapy sessions based on cognitive behavioral therapy to accompany their use of the app.

Behavioral: Self-help Smartphone AppBehavioral: Therapist-guided App Use

Waitlist control condition

NO INTERVENTION

Delayed use of the mobile application after 12 weeks.

Interventions

The app provides a 12-week adaptation of scientifically proven cognitive behavioral therapy techniques for the treatment of SAD and is intended for use as a mobile intervention. The app includes modules such as learning (e.g., creating a model, learning about the maintaining factors), changing the maintaining factors (e.g., safety behaviors), or behavioral experiments.

App conditionApp with accompanying therapy sessions

In addition to using the app, patients receive a total of 8 video-based therapy sessions over the course of 12 weeks. The sessions include topics such as video feedback and behavioral experiments.

App with accompanying therapy sessions

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current diagnosis of Social Anxiety Disorder
  • Written informed consent before the start of the study
  • Age: 18 to 65 years
  • Possession of smartphone
  • Familiarity with using smartphone apps

You may not qualify if:

  • Acute suicidality
  • Active substance abuse or dependence
  • Severe medical conditions (e.g., chronic cardiovascular disease)
  • Severe depression
  • Psychotic disorder
  • Bipolar disorder
  • Borderline personality disorder
  • Current psychotherapeutic treatment
  • Current psychopharmacological treatment
  • No proficient skills in the German language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Technische Universitaet Dresden

Dresden, 01187, Germany

RECRUITING

Goethe Universitaet Frankfurt

Frankfurt, 60486, Germany

RECRUITING

Study Officials

  • Ulrich Stangier, Professor

    Goethe University Frankfurt

    PRINCIPAL INVESTIGATOR
  • Jürgen Hoyer, Professor

    Technische Universitaet Dresden

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ulrich Stangier, Professor

CONTACT

Juergen Hoyer, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors are blinded to the conditions, but blinding of participant and care provider is not possible due to the nature of the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Comparison of self-help app only, self-help app plus accompanying therapy sessions, and waitlist control group
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2022

First Posted

September 26, 2022

Study Start

October 1, 2022

Primary Completion

October 1, 2023

Study Completion

October 1, 2023

Last Updated

September 26, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will share

The data used in this study is available from the corresponding authors upon reasonable request.

Locations